Author

Gabor Laszlo Veres 1

1 1st

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease

Frank Ruemmele, Gabor Laszlo Veres, Kaija-Leena Kolho, Anne Griffiths, Arie Levine, Johanna Caroline Escher, Jorge Amil Dias, Arrigo Barabino, Christian Braegger, Jiri Bronsky, Stephan Buderus, Javier Martín de Carpi, Lissy de Ridder, Ulrika Lorentzon Fagerberg, Jean-Pierre Hugot, J. Kierkus, Sanja Kolacek, Sibylle Koletzk

GUT BARRIER FAILURE BIOMARKERS ARE ASSOCIATED WITH POOR DISEASE OUTCOME IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS

Tornai Tamás, György Kovács, Zsuzsanna Vitális, István Tornai, Kai Fechner, Dirk Roggenbuck, David Tornai, Gary L. Norman, Gabor Laszlo Veres, Zakera Shums, Péter Orosz, Béla Lombay, Judit Gervain, Gabriella Par, Alajos Pár, Peter L Lakatos, Ferenc Szalay, Peter Antal-Szalmas, Mária Papp

IBD-RELATED MALIGNANCIES AND MORTALITIES OBSERVED BETWEEN 2015-2016 – TWO YEARS’ RESULTS FROM THE PROSPECTIVE NATIONWIDE HUNGARIAN REGISTRY

Tamás Molnár, Mariann Rutka, Ferenc Nagy, Péter Fritz, László Lakatos, Pal Miheller, Zsuzsanna Erdelyi, Tamás Szamosi, Eszter Schäfer, Aron Vincze, Patrícia Sarlós, János Banai, Ágota Kovács, János Novák, Ágnes Szabone Salamon, Attila Szepes, Nora Szigeti, Mark Juhasz, Katalin Müllner, Zsolt Barta, Orsolya Kadenczki, A

PEDIATRIC PANCREATITIS. MULTICENTRE PROSPECTIVE DATA COLLECTION AND ANALYSIS BY THE HUNGARIAN PANCREATIC STUDY GROUP

Andrea Parniczky, Natália Lásztity, Dóra Mosztbacher, Anna Tóth, Dániel Szűcs, Noémi Vass, Judit Czelecz, Csilla Andorka, Gabor Laszlo Veres, Ildikó Guthy, Richard Szmola, Balazs Nemeth, Anita Balazs, Miklós Sahin-Toth, Peter Hegyi

PRELIMINARY RESULTS FROM APPLE STUDY (ANALYSIS OF PEDIATRIC PANCREATITIS). MULTICENTRIC, INTERNATONAL, PROSPECTIVE, CLINICAL TRIAL

Andrea Parniczky, Balazs Nemeth, Dóra Mosztbacher, Anna Tóth, Alexandra Demcsák, Natália Lásztity, Andrea Szentesi, Gergely Tóth, Veronika Ila, Judit Czelecz, Csilla Andorka, Ildikó Guthy, István Tokodi, László Gárdos, Ibolya Vass, Andras Tarnok, Gabor Laszlo Veres, Peter Hegyi

RECONSIDERING THE PROGNOSTIC VALUE OF TRADITIONAL SEROLOGIC ANTIBODIES IN CROHN’S DISEASE – IMMUNOGLOBULIN CLASSES TO TAKE THE CENTRE STAGE

Nora Sipeki, Boglárka Suga, Gary L. Norman, Zakera Shums, Gabor Laszlo Veres, Peter L Lakatos, Peter Antal-Szalmas, Mária Papp

REDISCOVERY OF THE ANTI-PANCREATIC ANTIBODIES AND EVALUATION OF THEIR PROGNOSTIC VALUE IN A PROSPECTIVE CLINICAL COHORT OF CROHN'S PATIENTS: THE IMPORTANCE OF SPECIFIC TARGET ANTIGENS (GP2 AND CUZD1).

Mária Papp, Nora Sipeki, István Ferenc Altorjay, Gary L. Norman, Zakera Shums, Dirk Roggenbuck, Kai Fechner, Peter Antal-Szalmas, Gabor Laszlo Veres, Peter L Lakatos

RISK MATRIX FOR PREDICTION OF DISEASE PROGRESSION IN A REFERRAL COHORT OF PATIENTS WITH CROHN’S DISEASE

Peter L Lakatos, Nora Sipeki, Gary L. Norman, Zakera Shums, Peter Antal-Szalmas, Gabor Laszlo Veres, Mária Papp

SIGNIFICANCE OF SEROLOGICAL MARKERS IN THE DISEASE COURSE OF ULCERATIVE COLITIS

György Kovács, Nora Sipeki, Karoly Palatka, István Ferenc Altorjay, Kai Fechner, Gary L. Norman, Zakera Shums, Gabor Laszlo Veres, Peter L Lakatos, Mária Papp

SLC26A6 VARIANTS ARE NOT ASSOCIATED WITH CHRONIC PANCREATITIS

Anita Balazs, Eszter Hegyi, Balazs Nemeth, István Hritz, Ferenc Izbéki, Judit Gervain, Attila Zoltan Szepes, Zsolt Dubravcsik, Adrienn Csiszko, Dezső Kelemen, Zsolt Szentkereszty, Barnabas Bod, János Novák, Andrea Parniczky, Gabor Laszlo Veres, Richard Szmola, Judit Czelecz, Aron Vincze, Judit Bajor, Gyula Farkas, Lászl

Item 1 - 10 / 17
1
2